▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁more 11.640625
▁A 7.1328125
▁manage 11.7578125
able 0.13330078125
▁and 2.47265625
▁sa 4.33203125
fer 0.0015277862548828125
▁alternative 1.4345703125
▁might 6.62109375
▁be 0.178466796875
▁medical 2.44140625
▁mar 0.180419921875
iju 0.004474639892578125
ana 0.0006971359252929688
. 1.462890625
▁However 2.98828125
, 0.009979248046875
▁the 1.61328125
▁legal 4.41796875
▁status 1.150390625
▁and 2.73046875
▁novel 9.21875
ty 0.73046875
▁of 0.197265625
▁this 1.62109375
▁drug 2.01953125
▁do 4.98046875
▁not 0.0716552734375
▁allow 1.0322265625
▁finding 8.7109375
▁a 2.318359375
▁large 4.3203125
▁number 1.3837890625
▁of 0.00490570068359375
▁studies 1.2958984375
▁on 1.5224609375
▁its 0.990234375
▁effect 2.0859375
iveness 0.461181640625
. 1.0927734375
▁Specifically 8.2421875
, 0.12066650390625
▁it 2.73046875
▁concerns 5.0234375
▁the 0.60888671875
▁emot 7.4609375
ional 0.0169677734375
▁condition 5.375
▁of 0.37109375
▁patients 0.70166015625
▁experien 6.37890625
cing 5.8531761169433594e-05
▁chron 1.1015625
ic 0.0023555755615234375
▁pain 0.1024169921875
. 0.66015625
▁This 3.212890625
▁research 3.0234375
▁paper 6.44921875
▁a 2.1640625
ims 0.0004124641418457031
▁to 0.08685302734375
▁analyze 3.08203125
▁levels 9.6875
▁of 0.037872314453125
▁de 0.5703125
pression 0.037841796875
▁and 0.27001953125
▁anx 0.0413818359375
iety 0.0012464523315429688
▁among 0.81103515625
▁people 3.294921875
▁receiving 0.93896484375
▁ther 7.96484375
apy 0.32666015625
▁by 5.21875
▁comparing 8.203125
▁the 0.98876953125
▁effects 2.125
▁of 0.0299224853515625
▁ph 2.4375
arma 0.04681396484375
ce 0.0012750625610351562
ut 7.009506225585938e-05
ical 0.003635406494140625
▁op 0.31103515625
io 0.1708984375
ids 0.059600830078125
▁and 0.2685546875
▁MM 1.3134765625
. 1.0458984375
<0x0A> 1.1611328125
The 1.3447265625
▁study 2.068359375
▁was 2.13671875
▁conducted 0.74462890625
▁in 1.5390625
▁the 1.373046875
▁form 2.169921875
▁of 0.0078887939453125
▁collection 9.9375
▁and 1.7138671875
▁analysis 0.716796875
▁of 0.047698974609375
▁statistical 4.0703125
▁data 0.12646484375
. 0.98583984375
▁Part 4.91796875
icip 0.06329345703125
ants 0.04541015625
▁were 0.708984375
▁rec 3.275390625
ru 0.001068115234375
ited 7.200241088867188e-05
▁for 4.05859375
▁six 7.4765625
▁months 0.4658203125
▁at 3.765625
▁two 2.58203125
▁major 5.46484375
▁pain 3.357421875
▁relief 5.2109375
▁cent 1.470703125
ers 0.0755615234375
▁in 0.7294921875
▁Israel 4.26953125
. 0.443359375
▁The 1.18359375
▁research 2.2265625
ers 1.431640625
▁used 2.666015625
▁The 7.87109375
▁De 4.1796875
pression 0.0126953125
▁Module 10.1171875
▁of 0.9833984375
▁the 0.323486328125
▁Pat 2.376953125
ient 0.00794219970703125
▁Health 0.08453369140625
▁Question 0.016143798828125
naire 0.0191497802734375
▁and 3.345703125
▁the 0.69287109375
▁General 1.6748046875
ized 0.685546875
▁An 0.01739501953125
x 0.00016832351684570312
iety 0.00316619873046875
▁Dis 0.5048828125
order 0.035003662109375
▁Sc 1.1865234375
ale 0.07421875
▁to 1.796875
▁interview 7.15234375
▁participants 2.06640625
, 3.6328125
▁evaluate 5.62109375
▁their 0.775390625
▁answers 6.515625
, 0.96484375
▁and 0.1551513671875
▁conduct 4.4921875
▁the 2.3671875
▁study 2.169921875
. 0.225830078125
▁To 5.0703125
▁specifically 9.9609375
▁evaluate 2.501953125
▁and 4.359375
▁compare 0.99267578125
▁the 0.315673828125
▁prob 11.203125
abilities 0.193359375
▁of 0.1328125
▁de 0.7919921875
pression 0.039642333984375
▁or 4.734375
▁anx 0.0369873046875
iety 0.0002999305725097656
▁among 1.6787109375
▁the 2.23046875
▁diverse 8.9609375
▁groups 1.5830078125
, 1.4462890625
▁the 1.01171875
▁study 2.640625
▁used 1.5927734375
▁multiple 4.72265625
▁log 2.90234375
istic 0.037506103515625
▁regression 0.09686279296875
▁analysis 0.65966796875
▁and 2.517578125
▁chose 8.8125
▁medical 7.46484375
▁mar 0.36083984375
iju 0.0017490386962890625
ana 0.0002294778823852539
▁as 0.7783203125
▁the 1.13671875
▁control 2.650390625
▁group 0.53271484375
. 0.297119140625
<0x0A> 0.8779296875
This 3.474609375
▁type 6.125
▁of 0.007965087890625
▁study 1.6552734375
▁is 1.2724609375
▁the 3.3671875
▁most 1.9267578125
▁reve 9.2421875
aling 0.00067138671875
▁and 1.0615234375
▁inclus 6.4921875
ive 0.0023212432861328125
, 2.236328125
▁as 1.974609375
▁it 0.358642578125
▁contains 4.87890625
▁direct 6.33984375
▁responses 5.00390625
▁from 0.82470703125
▁a 3.84765625
▁large 0.8779296875
▁number 0.4345703125
▁of 0.0033664703369140625
▁participants 1.48828125
. 0.669921875
▁All 4.7265625
▁tools 9.078125
▁in 4.51953125
▁the 0.67529296875
▁form 3.556640625
▁of 0.04425048828125
▁question 1.8291015625
na 0.041595458984375
ires 9.02414321899414e-05
▁and 2.16015625
▁scales 3.046875
▁have 3.578125
▁already 4.4765625
▁been 0.1771240234375
▁used 1.947265625
▁and 2.103515625
▁proved 4.265625
▁their 1.814453125
▁effic 4.0234375
acy 6.771087646484375e-05
▁for 3.66015625
▁collect 4.609375
ing 0.017669677734375
▁analyt 8.296875
ical 0.2294921875
▁data 0.27587890625
. 0.4365234375
▁It 3.658203125
▁helps 4.83984375
▁to 0.9423828125
▁system 7.41796875
at 1.3447265625
ize 0.006011962890625
▁and 1.607421875
▁class 3.990234375
ify 0.00225067138671875
▁distinct 9.40625
▁kinds 6.421875
▁of 0.026214599609375
▁information 3.494140625
▁for 3.912109375
▁subsequent 3.990234375
▁un 8.03125
comp 5.4921875
licated 0.0693359375
▁services 11.6484375
. 0.6103515625
▁Thus 4.55078125
, 0.0283203125
▁research 4.5
ers 0.57421875
▁can 1.3515625
▁compare 3.990234375
▁the 0.9267578125
▁effects 3.015625
▁of 0.1058349609375
▁medic 4.47265625
ations 0.93701171875
▁on 1.7626953125
▁patients 2.09375
▁of 4.56640625
▁diverse 4.1171875
▁age 2.84375
▁groups 0.66552734375
, 0.912109375
▁background 5.11328125
s 0.2098388671875
, 0.0789794921875
▁physical 5.34765625
▁conditions 1.4580078125
, 0.09393310546875
▁emot 5.6015625
ional 0.05718994140625
▁states 1.4091796875
, 0.11383056640625
▁and 0.452880859375
▁so 3.185546875
▁on 0.322509765625
. 0.095947265625
<0x0A> 0.6669921875
The 1.0810546875
▁analysis 4.58984375
▁of 0.5703125
▁any 8.96875
▁human 6.16796875
▁reaction 4.9609375
▁has 4.609375
▁a 1.7138671875
▁high 4.41015625
▁potential 3.5234375
▁subject 10.8828125
iveness 4.27734375
▁of 3.755859375
▁and 9.4609375
▁bias 3.61328125
, 2.107421875
▁especially 2.755859375
▁regarding 4.40234375
▁people 4.578125
▁in 3.8125
▁severe 4.26953125
▁pain 0.31787109375
▁and 2.673828125
▁un 5.2578125
stable 1.892578125
▁emot 0.87841796875
ional 0.1724853515625
▁condition 2.693359375
. 0.0855712890625
▁Perhaps 8.7421875
▁some 5.0
▁patients 2.40625
▁tend 5.46875
▁to 0.0229034423828125
▁ex 2.54296875
agger 0.0017070770263671875
ate 0.006114959716796875
▁their 0.78662109375
▁de 5.16796875
press 1.3681640625
ive 0.267578125
▁state 3.1171875
▁or 1.8974609375
▁vice 7.4453125
▁vers 0.015594482421875
a 8.630752563476562e-05
, 1.0771484375
▁de 7.30859375
- 5.00390625
emph 1.0693359375
as 0.006290435791015625
ize 0.1551513671875
▁serious 6.64453125
▁difficulties 6.046875
. 0.88720703125
▁Because 6.140625
▁the 2.09375
▁survey 6.09375
▁responses 6.73828125
▁were 1.7421875
▁thoroughly 7.99609375
▁anonymous 5.1328125
, 0.47509765625
▁the 1.4404296875
▁research 1.625
ers 0.300048828125
▁were 1.4736328125
▁unable 2.275390625
▁to 0.0036773681640625
▁carefully 8.71875
▁analyze 1.654296875
▁each 4.0859375
▁patient 2.43359375
’ 27.171875
s 0.9384765625
▁reaction 3.71875
▁and 2.36328125
▁compare 3.6171875
▁it 0.951171875
▁to 1.2841796875
▁the 0.73779296875
▁actual 5.5625
▁states 7.24609375
▁of 0.71435546875
▁condition 7.19140625
. 0.396728515625
▁More 5.63671875
▁accurate 5.12890625
▁answers 4.70703125
▁could 2.5234375
▁be 0.89990234375
▁obtained 0.99267578125
▁by 1.3837890625
▁professional 7.47265625
▁psych 2.189453125
olog 0.34228515625
ists 0.00128936767578125
▁via 7.96484375
▁personal 3.8984375
▁communication 4.5859375
▁and 1.853515625
▁behavior 7.17578125
al 0.343505859375
▁analysis 2.337890625
. 0.2392578125
▁However 2.955078125
, 0.0041656494140625
▁this 1.9150390625
▁method 2.845703125
▁of 2.326171875
▁research 2.12890625
▁is 0.92041015625
▁way 8.0
▁more 1.7587890625
▁resource 6.55078125
- 0.50830078125
int 0.53173828125
ensive 0.00876617431640625
▁and 0.62890625
▁energy 8.6484375
- 0.129150390625
consum 0.322509765625
ing 0.0020465850830078125
. 0.6240234375
<0x0A> 0.6162109375
Part 5.52734375
icip 0.097412109375
ants 0.11749267578125
▁were 1.0009765625
▁rec 1.5341796875
ru 0.0011682510375976562
ited 0.00010025501251220703
▁for 1.1201171875
▁six 1.1123046875
▁months 0.018341064453125
▁at 0.444091796875
▁two 0.1090087890625
▁major 0.339111328125
▁pain 0.03558349609375
▁relief 0.032440185546875
▁cent 0.0310821533203125
ers 0.005496978759765625
▁in 0.059417724609375
▁Israel 0.032470703125
. 0.14501953125
▁All 3.541015625
▁patients 1.52734375
▁experienced 5.671875
▁chron 1.830078125
ic 0.0026226043701171875
▁pain 0.10205078125
▁for 3.455078125
▁at 0.7333984375
▁least 0.0009870529174804688
▁ 1.03125
3 1.451171875
▁months 0.216064453125
. 1.0439453125
▁The 1.4814453125
▁study 1.9345703125
▁included 2.134765625
▁ 1.111328125
8 2.87109375
9 2.767578125
0 3.640625
▁participants 1.53515625
, 1.2451171875
▁of 1.7216796875
▁which 0.4208984375
▁ 0.1490478515625
4 1.61328125
7 2.462890625
4 2.740234375
▁( 2.123046875
5 0.0946044921875
9 11.171875
%) 1.0419921875
▁were 0.480224609375
▁treated 4.5859375
▁sole 6.8828125
ly 0.00013208389282226562
▁with 0.457763671875
▁op 0.8046875
io 0.385986328125
ids 0.197265625
, 1.146484375
▁ 0.57666015625
3 1.0751953125
2 2.07421875
9 2.55078125
▁( 0.04473876953125
4 1.1796875
1 1.2587890625
%) 0.1343994140625
▁were 1.3310546875
▁treated 0.52978515625
▁with 0.1856689453125
▁MM 0.748046875
, 0.262451171875
▁and 0.159423828125
▁ 0.136962890625
7 3.228515625
7 2.412109375
▁( 0.17626953125
8 3.734375
. 1.1416015625
6 2.982421875
%) 0.05511474609375
▁acquired 9.796875
▁both 1.1650390625
▁( 6.9765625
Fe 10.0625
ing 2.865234375
old 0.0198516845703125
▁et 1.4130859375
▁al 0.017791748046875
., 0.332275390625
▁ 0.0110931396484375
2 0.1680908203125
0 0.000423431396484375
1 0.400390625
7 2.0703125
). 0.1484375
▁The 1.345703125
▁remaining 6.97265625
▁ten 8.09375
▁participants 1.4111328125
▁who 5.55859375
▁did 1.4677734375
▁not 0.006664276123046875
▁receive 1.8671875
▁ph 3.05859375
arma 0.06689453125
ce 0.0015583038330078125
ut 2.0742416381835938e-05
ical 0.00341033935546875
▁op 1.029296875
io 0.0777587890625
ids 0.0235443115234375
▁and 1.6513671875
▁medical 2.373046875
▁mar 0.046600341796875
iju 0.00439453125
ana 9.5367431640625e-05
▁were 1.2861328125
▁with 5.953125
dra 0.134033203125
wn 0.00011289119720458984
▁from 0.267333984375
▁the 0.11053466796875
▁analysis 4.6484375
▁in 4.7734375
▁the 1.173828125
▁research 4.2578125
. 0.72314453125
▁Therefore 4.98828125
, 0.01013946533203125
▁it 3.896484375
▁is 0.92822265625
▁not 2.705078125
▁possible 0.6611328125
▁to 0.02130126953125
▁compreh 6.57421875
ens 0.054046630859375
ively 0.009521484375
▁compare 1.8603515625
▁patients 4.7421875
▁taking 4.265625
▁medic 3.8828125
ations 0.498779296875
▁with 1.013671875
▁those 1.201171875
▁who 1.1376953125
▁do 1.697265625
▁not 0.00861358642578125
. 0.77294921875
<0x0A> 0.66357421875
The 1.1240234375
▁study 1.6845703125
▁conducted 4.8125
▁a 2.0546875
▁correlation 5.93359375
▁type 7.30859375
▁of 0.489990234375
▁research 1.91796875
▁with 2.822265625
▁variable 8.0
▁measures 4.5703125
. 1.2919921875
▁It 2.21484375
▁evaluated 4.38671875
▁the 0.55419921875
▁inter 6.30859375
dep 3.623046875
end 0.0005960464477539062
ence 0.0108795166015625
▁of 0.568359375
▁various 3.947265625
▁factors 1.65625
▁that 2.8046875
▁affected 4.1328125
▁the 0.56201171875
▁physical 6.875
▁and 0.9560546875
▁emot 0.486083984375
ional 0.00038814544677734375
▁condition 1.0205078125
▁of 0.11248779296875
▁patients 0.609375
▁experien 4.203125
cing 2.2411346435546875e-05
▁chron 0.57763671875
ic 0.0005254745483398438
▁pain 0.0292205810546875
. 0.2247314453125
▁For 3.77734375
▁example 1.06640625
, 0.0188446044921875
▁the 1.20703125
▁survey 5.2265625
▁showed 3.388671875
▁that 0.40625
▁the 1.697265625
▁ratio 7.02734375
▁of 0.1173095703125
▁female 4.4609375
▁patients 0.78564453125
▁was 1.8486328125
▁remark 9.5234375
ably 0.0005469322204589844
▁higher 0.5263671875
▁in 2.685546875
▁the 0.91064453125
▁op 4.5546875
i 4.08984375
ates 0.090576171875
▁group 0.271728515625
▁compared 2.732421875
▁to 0.128662109375
▁the 0.52197265625
▁MM 0.454833984375
▁group 0.28515625
. 0.48095703125
▁In 2.921875
▁turn 4.046875
, 0.00394439697265625
▁people 6.05859375
▁on 5.51953125
▁op 1.3466796875
i 0.4306640625
ates 0.0033016204833984375
▁were 1.03515625
▁more 0.99853515625
▁likely 0.380859375
▁to 0.06280517578125
▁report 3.1484375
▁major 5.9765625
▁de 0.39599609375
press 1.2392578125
ive 0.003704071044921875
▁dis 0.5244140625
orders 1.3369140625
. 1.7568359375
<0x0A> 2.455078125
The 1.1328125
▁question 5.8125
na 1.4111328125
ires 8.678436279296875e-05
▁used 1.990234375
▁different 8.1484375
▁variable 8.59375
▁measures 0.83544921875
▁to 1.3759765625
▁collect 2.3828125
▁information 1.9267578125
. 1.640625
▁For 1.962890625
▁example 0.1805419921875
, 0.009368896484375
▁it 4.0859375
▁included 2.560546875
▁compreh 8.640625
ensive 0.0284423828125
▁so 6.84765625
cio 0.02490234375
- 0.388427734375
dem 0.08258056640625
ographic 0.03863525390625
▁data 1.009765625
: 4.86328125
▁gender 1.6259765625
, 0.090576171875
▁age 0.20166015625
, 0.08837890625
▁country 4.37890625
, 1.4609375
▁type 4.34765625
▁of 0.061981201171875
▁residence 3.8515625
▁( 3.458984375
urban 2.052734375
/ 2.93359375
r 0.06683349609375
ural 0.0005240440368652344
), 0.2359619140625
▁years 5.96484375
▁of 0.168701171875
▁education 0.68896484375
, 0.1510009765625
▁and 1.8525390625
▁employ 3.630859375
ment 0.00414276123046875
▁status 0.44873046875
. 0.1827392578125
▁Pat 4.10546875
ients 0.10113525390625
▁were 1.134765625
▁also 0.87646484375
▁asked 0.62353515625
▁about 1.125
▁their 0.6142578125
▁medical 2.734375
▁history 0.412353515625
▁over 8.7734375
▁the 0.159423828125
▁years 4.01171875
▁and 1.818359375
▁the 1.81640625
▁current 3.3828125
▁presence 5.72265625
▁of 0.05712890625
▁any 2.681640625
▁severe 4.56640625
▁dise 1.4775390625
ases 8.857250213623047e-05
▁such 4.19921875
▁as 0.00437164306640625
▁heart 2.390625
▁failure 2.044921875
, 0.189697265625
▁di 1.853515625
ab 0.0018415451049804688
etes 0.00437164306640625
, 0.127685546875
▁ar 3.77734375
th 0.1278076171875
rit 0.032012939453125
is 0.01212310791015625
, 0.044219970703125
▁and 1.5537109375
▁so 0.76513671875
▁on 0.0291290283203125
. 0.050262451171875
▁The 1.8828125
▁third 7.1796875
▁measure 3.95703125
▁of 2.048828125
▁the 0.99560546875
▁question 2.84765625
naire 0.1461181640625
▁was 1.0048828125
▁indicated 9.8125
▁by 0.60205078125
▁information 6.4375
▁on 1.5693359375
▁any 5.375
▁twelve 13.6484375
- 1.1611328125
month 0.35693359375
▁and 5.765625
▁lifetime 3.177734375
▁drug 4.64453125
▁and 3.447265625
▁alco 0.0789794921875
hol 8.702278137207031e-05
▁consumption 2.595703125
. 0.469970703125
▁In 3.455078125
▁addition 0.767578125
, 0.1253662109375
▁the 1.1357421875
▁record 7.8203125
▁included 1.748046875
▁a 2.45703125
▁pain 6.40234375
▁measurement 4.28515625
▁scale 1.015625
▁from 3.65625
▁ 0.467041015625
0 0.430908203125
▁to 0.413330078125
▁ 0.00701904296875
1 0.08782958984375
0 0.07275390625
▁to 4.5703125
▁evaluate 1.57421875
▁dis 5.96484375
com 0.21533203125
fort 0.0012598037719726562
▁feelings 7.3125
▁during 3.26953125
▁the 0.91064453125
▁last 1.423828125
▁month 1.591796875
. 0.27978515625
<0x0A> 1.138671875
Am 6.859375
ong 0.01323699951171875
▁all 2.384765625
▁participants 1.94140625
▁in 3.517578125
▁the 0.1783447265625
▁study 0.380126953125
, 0.060211181640625
▁ 0.6513671875
4 1.759765625
2 2.734375
. 1.791015625
2 2.298828125
% 0.139892578125
▁suffered 4.8125
▁from 0.1397705078125
▁de 1.7568359375
pression 0.1578369140625
, 1.0634765625
▁and 1.736328125
▁ 0.150634765625
3 1.7158203125
7 2.232421875
% 2.7578125
▁experienced 2.349609375
▁excess 7.83203125
ive 0.0968017578125
▁anx 0.25732421875
iety 0.001461029052734375
. 0.340576171875
▁The 1.43359375
▁pl 11.1875
ur 1.0390625
ality 0.00021708011627197266
▁of 0.197021484375
▁de 3.51171875
press 1.2763671875
ive 0.02337646484375
▁dis 1.81640625
orders 0.060333251953125
▁among 3.767578125
▁patients 1.208984375
▁in 3.59765625
▁the 0.3662109375
▁op 1.4423828125
i 0.9921875
ates 0.004547119140625
, 7.10546875
▁medical 2.9609375
▁mar 0.0215606689453125
iju 0.005733489990234375
ana 3.1948089599609375e-05
, 0.12432861328125
▁and 0.063720703125
▁mixed 6.08203125
▁OP 8.78125
MM 5.6796875
▁groups 0.44384765625
▁number 8.0703125
ed 0.0122528076171875
▁ 0.120849609375
5 2.193359375
7 2.484375
. 0.2100830078125
1 2.3671875
%, 0.24755859375
▁ 0.004627227783203125
2 3.0078125
2 2.431640625
. 0.1026611328125
3 2.23046875
%, 0.11871337890625
▁and 0.031463623046875
▁ 0.0030517578125
5 3.212890625
1 2.5703125
. 0.1646728515625
4 2.142578125
%, 0.384033203125
▁respectively 0.01007080078125
. 0.27685546875
▁The 1.4736328125
▁pl 4.5546875
ur 0.021697998046875
ality 3.349781036376953e-05
▁of 0.040679931640625
▁anx 0.8935546875
iety 0.0103759765625
▁contained 11.046875
▁ 0.626953125
4 1.5830078125
8 2.37890625
. 0.061309814453125
4 2.3125
% 0.51611328125
▁among 1.4482421875
▁OP 6.38671875
▁patients 9.015625
, 0.272705078125
▁ 0.09539794921875
2 1.5078125
1 2.412109375
. 0.1295166015625
5 2.43359375
% 0.01139068603515625
▁among 0.43701171875
▁MM 0.34033203125
▁patients 0.2470703125
, 0.01248931884765625
▁and 0.01300048828125
▁ 0.03924560546875
3 1.2392578125
8 2.6484375
. 0.15380859375
7 2.29296875
% 0.01334381103515625
▁among 0.2430419921875
▁OP 3.984375
MM 0.216064453125
▁participants 3.623046875
. 0.2171630859375
▁Pat 5.81640625
ients 0.022369384765625
▁who 2.376953125
▁took 2.93359375
▁strong 8.203125
▁op 1.24609375
i 1.396484375
ates 0.00327301025390625
▁were 1.7216796875
▁t 8.9140625
ended 1.2490234375
▁to 0.01398468017578125
▁place 10.3203125
▁their 3.66796875
▁pain 2.59375
▁on 3.4453125
▁a 0.86962890625
▁scale 2.291015625
▁of 0.61962890625
▁ 0.35546875
9 2.810546875
▁to 1.3505859375
▁ 0.01543426513671875
1 0.022674560546875
0 0.09088134765625
▁( 2.568359375
Fe 1.6328125
ing 0.00801849365234375
old 0.00045371055603027344
▁et 0.03240966796875
▁al 0.0008935928344726562
., 0.00789642333984375
▁ 0.001796722412109375
2 0.0006175041198730469
0 3.2067298889160156e-05
1 0.0020771026611328125
7 0.014190673828125
). 0.05804443359375
▁They 4.71875
▁were 1.283203125
▁also 1.3896484375
▁an 8.84375
gu 4.6328125
ished 0.03509521484375
▁em 8.46875
otion 0.01076507568359375
ally 0.00405120849609375
▁and 1.1455078125
▁react 6.8515625
ed 0.0614013671875
▁rad 9.4765625
ically 0.0031604766845703125
▁neg 5.25390625
atively 0.0010776519775390625
▁to 0.3447265625
▁almost 5.29296875
▁all 1.1748046875
▁survey 8.53125
▁questions 0.646484375
. 0.2939453125
▁Pat 4.35546875
ients 0.00788116455078125
▁who 1.1533203125
▁took 1.4873046875
▁only 5.4453125
▁MM 0.87939453125
▁or 3.220703125
▁mixed 3.3515625
▁medic 2.62890625
ations 0.337646484375
▁course 12.609375
▁had 2.51953125
▁a 1.255859375
▁significantly 2.54296875
▁more 4.1015625
▁stable 3.3984375
▁emot 1.193359375
ional 0.007022857666015625
▁state 0.8203125
▁and 1.412109375
▁cop 5.58984375
ed 0.82666015625
▁with 0.73291015625
▁pain 1.46875
▁more 1.6484375
▁manage 7.08984375
able 2.337890625
. 0.517578125
<0x0A> 0.6923828125
One 5.21875
▁of 0.63232421875
▁the 0.0186004638671875
▁major 2.521484375
▁limitations 2.72265625
▁is 3.896484375
▁the 0.5390625
▁ins 4.734375
u 0.0189208984375
fficient 0.11822509765625
ly 4.7421875
▁high 3.00390625
▁response 3.0078125
▁rate 0.1234130859375
, 2.609375
▁ 4.65625
5 1.923828125
7 2.04296875
% 2.119140625
▁instead 7.26953125
▁of 0.007598876953125
▁ 0.71337890625
7 1.521484375
0 1.47265625
% 1.130859375
▁( 1.6474609375
Fe 0.260009765625
ing 0.003658294677734375
old 0.0004911422729492188
▁et 0.007114410400390625
▁al 0.0006170272827148438
., 0.00537109375
▁ 0.0014333724975585938
2 0.00045800209045410156
0 2.3245811462402344e-05
1 0.0009746551513671875
7 0.006927490234375
). 0.041748046875
▁It 2.72265625
▁can 3.291015625
▁be 0.407470703125
▁fairly 8.296875
▁explained 1.5947265625
▁by 0.173828125
▁the 0.32177734375
▁weak 8.1875
▁focus 7.16796875
▁of 0.463623046875
▁respond 6.30859375
ents 0.1357421875
▁who 3.455078125
▁have 4.03515625
▁overcome 8.0390625
▁severe 2.27734375
▁pain 0.4873046875
▁sens 8.6953125
ations 1.150390625
▁and 1.19921875
▁de 4.2109375
press 1.7734375
ive 0.251708984375
▁episodes 3.9453125
. 0.61474609375
▁It 3.41015625
▁is 0.822265625
▁not 2.65234375
▁clear 4.13671875
▁how 1.6708984375
▁to 3.529296875
▁use 5.3828125
▁these 3.01953125
▁statistics 3.44140625
, 2.5703125
▁as 1.4912109375
▁they 1.3603515625
▁still 6.07421875
▁may 4.84375
▁be 1.365234375
▁relevant 5.34375
▁for 1.4345703125
▁the 1.84375
▁overall 4.515625
▁analysis 3.125
. 1.1171875
